NB
EW icon

NBT Bank’s Edwards Lifesciences EW Stock Holding History

NBT Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.1K Buy
551
+5
+0.9% +$412 ﹤0.01% 513
2025
Q4 		$46.5K Hold
546
– – ﹤0.01% 508
2025
Q3 		$42.5K Hold
546
– – ﹤0.01% 515
2025
Q2 		$42.7K Hold
546
– – ﹤0.01% 520
2025
Q1 		$39.6K Hold
546
– – ﹤0.01% 517
2024
Q4 		$40.4K Hold
546
– – ﹤0.01% 521
2024
Q3 		$36K Buy
+546
New +$39.7K ﹤0.01% 556
2018
Q3 		– Sell
-4,836
Closed -$235K – 188
2018
Q2 		$235K Hold
4,836
– – 0.04% 171
2018
Q1 		$225K Buy
+4,836
New +$210K 0.04% 187

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

NBT Bank's EW Position: Q1 2026 in Review

NBT Bank increased its Edwards Lifesciences (EW) stake by 0.92% in Q1 2026, buying an estimated $412 and bringing the position to 551 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

NBT Bank first reported a position in EW in Q1 2018 and has held it in 9 quarters since. The position peaked at $235K in Q2 2018. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • NBT Bank held 551 shares of Edwards Lifesciences worth $44.1K as of Q1 2026.
  • NBT Bank bought 5 Edwards Lifesciences shares in Q1 2026, an estimated $412.
  • Edwards Lifesciences made up ﹤0.01% of NBT Bank's portfolio in Q1 2026, its #513 holding.
  • NBT Bank first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 9 quarters since.
  • NBT Bank's Edwards Lifesciences position peaked at $235K in Q2 2018.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.